Shares of genedrive plc (LON:GDR – Get Free Report) shot up 10% during mid-day trading on Wednesday . The company traded as high as GBX 0.88 and last traded at GBX 0.88. 4,591,832 shares were traded during mid-day trading, a decline of 76% from the average session volume of 18,979,752 shares. The stock had previously closed at GBX 0.80.
genedrive Stock Performance
The firm has a market capitalization of £9.27 million, a price-to-earnings ratio of -0.42 and a beta of -0.04. The firm’s 50-day moving average price is GBX 0.89 and its two-hundred day moving average price is GBX 0.89. The company has a debt-to-equity ratio of 0.35, a quick ratio of 5.52 and a current ratio of 4.60.
About genedrive
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
See Also
- Five stocks we like better than genedrive
- Bombshell Exposé on China Strikes
- Do not delete, read immediately
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Trump’s new AI budget just passed — one stock could soar
- $4,200 gold is nice … but here’s what most gold bugs are missing
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
